ONCOSIGNATURE Trademark
Serial Number: 79223972 • Registration: 5718472
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Sara M. Bauer Womble Bond Dickinson (US) LLP
470 Atlantic Ave; Suite 600
Independence Wharf
Boston, MA 02210
United States
Trademark Details
Filing Date
September 22, 2017
Registration Date
April 9, 2019
Published for Opposition
January 22, 2019
Goods & Services
[ Pharmaceutical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; medical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; veterinary pharmaceutical preparations for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; pharmaceutical and medical preparations for treatment, prevention and alleviation of cancer; pharmaceutical and medical preparations for the prediction of drug treatment efficacy; pharmaceutical and medical preparations for prognosis related to cancer; biological preparations for medical and veterinary purposes, namely, for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing, specifically in oncology and premalignant disorders and benign tumors; chemical preparations for therapeutic use, namely, for pharmaceutical or medical purposes, namely, for use in oncology, specifically the prevention, alleviation and treatment of cancer and precancerous diseases and benign tumors; reagents for medical use, namely, for medical diagnosis, drug-tailored efficacy prediction and/or analysis; clinical medical reagents; diagnostic preparations for medical and veterinary purposes; diagnostic test materials for medical use in the field of oncology in the form of a clinical biomarker signature assay on biopsy or other patient sample material for measuring biomarkers reflective of disease-driving processes that the drug inhibits and does not inhibit to predict treatment efficacy within oncology; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; companion diagnostic biomarker reagents for medical purposes ]
Scientific and technological research and consultation services, namely, in the medical, pharmaceutical, and scientific research fields of drug-tailored, efficacy-predictive biomarkers, pharmacodynamic biomarkers, drug repurposing, and identification of rational drug combinations; industrial analysis and research services, namely, industrial research in the field of oncology; basic medical research and medical clinical research, hereunder for development of therapeutics; drug discovery services; consultancy in the field of pharmaceutical research and development; medical and scientific research related to cancer and cancer therapy, including research related to treatment, prevention and alleviation of cancer; pharmaceutical research services related to prediction of drug treatment efficacy; medical research services related to cancer diagnosis, cancer prognosis and drug-tailored efficacy prediction; medical research, namely, analysis related to cancer diagnosis, cancer prognosis and drug-tailored efficacy prediction
